Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal

Showing results (211-220 of 276) with videos related to

Pageof 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 3, 2021
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology GroupImke Grimmelmann, Michael Momma, Lisa Zimmer, et al.
Nature Communications|February 24, 2026
Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune responseCléa Dziagwa, Christian Seca, Coralie Capron, et al.
Oncotarget|October 23, 2018
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter studyJulia K Tietze, Andrea Forschner, Carmen Loquai, et al.
Elife|September 5, 2018
Topography of cancer-associated immune cells in human solid tumorsJakob Nikolas Kather, Meggy Suarez-Carmona, Pornpimol Charoentong, et al.
Journal of Extracellular Vesicles|September 27, 2023
Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytesEmma Rigg, Jiwei Wang, Zhiwei Xue, et al.
Frontiers in Immunology|June 21, 2024
Clinical and genetic characteristics of <i>BAP1</i>-mutated non-uveal and uveal melanomaJohanna Matull, Jan-Malte Placke, Georg Lodde, et al.
Oncotarget|November 5, 2017
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trialSelma Ugurel, Carmen Loquai, Patrick Terheyden, et al.
International Journal of Cardiology|February 7, 2018
Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytesIbrahim El-Battrawy, Zhihan Zhao, Huan Lan, et al.
Melanoma Management|December 25, 2019
Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart reviewPeter Mohr, Felix Kiecker, Virtudes Soriano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Pageof 28

Showing results (211-220 of 276) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|April 3, 2021
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology GroupImke Grimmelmann, Michael Momma, Lisa Zimmer, et al.
Nature Communications|February 24, 2026
Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune responseCléa Dziagwa, Christian Seca, Coralie Capron, et al.
Oncotarget|October 23, 2018
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter studyJulia K Tietze, Andrea Forschner, Carmen Loquai, et al.
Elife|September 5, 2018
Topography of cancer-associated immune cells in human solid tumorsJakob Nikolas Kather, Meggy Suarez-Carmona, Pornpimol Charoentong, et al.
Journal of Extracellular Vesicles|September 27, 2023
Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytesEmma Rigg, Jiwei Wang, Zhiwei Xue, et al.
Frontiers in Immunology|June 21, 2024
Clinical and genetic characteristics of <i>BAP1</i>-mutated non-uveal and uveal melanomaJohanna Matull, Jan-Malte Placke, Georg Lodde, et al.
Oncotarget|November 5, 2017
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trialSelma Ugurel, Carmen Loquai, Patrick Terheyden, et al.
International Journal of Cardiology|February 7, 2018
Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytesIbrahim El-Battrawy, Zhihan Zhao, Huan Lan, et al.
Melanoma Management|December 25, 2019
Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart reviewPeter Mohr, Felix Kiecker, Virtudes Soriano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Pageof 28